Assessment of obstructive sleep apnoea treatment success or failure after maxillomandibular advancement

M.H.T. de Ruiter, R.C. Apperloo, D.M.J. Milstein, J. de Lange

Research output: Contribution to JournalArticleAcademicpeer-review


Maxillomandibular advancement (MMA) is an alternative therapeutic option that is highly effective for treating obstructive sleep apnoea (OSA). MMA provides a solution for OSA patients that have difficulty accepting lifelong treatments with continuous positive airway pressure or mandibular advancement devices. The goal of this study was to investigate the different characteristics that determine OSA treatment success/failure after MMA. The apnoea–hypopnoea index (AHI) was used to determine the success or failure of OSA treatment after MMA. Sixty-two patients underwent MMA for moderate and severe OSA. A 71% success rate was observed with a mean AHI reduction of 69%. A statistically significant larger neck circumference was measured in patients with failed OSA treatments following MMA (P = 0.008), and older patients had failed OSA treatments with MMA: 58 vs. 53 years respectively (P = 0.037). Cephalometric analysis revealed no differences between successful and failed OSA treatment outcomes. There was no difference in maxillary and mandibular advancements between success and failed MMA-treated OSA patients. The complications most frequently reported following MMA were sensory disturbances in the inferior alveolar nerve (60%) and malocclusion (24%). The results suggest that age and neck girth may be important factors that could predict susceptibility to OSA treatment failures by MMA
Original languageEnglish
Pages (from-to)1357-1362
JournalInternational Journal of Oral and Maxillofacial Surgery
Issue number11
Publication statusPublished - 2017


Dive into the research topics of 'Assessment of obstructive sleep apnoea treatment success or failure after maxillomandibular advancement'. Together they form a unique fingerprint.

Cite this